Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
10
×
Tags
biotech
10
×
boston blog main
10
×
life sciences
national blog main
boston top stories
national top stories
new york blog main
san francisco blog main
new york top stories
san diego blog main
san francisco top stories
indiana blog main
indiana top stories
san diego top stories
texas top stories
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
boston
clinical trials
drugs
gene therapy
alirocumab
deals
department of health and human services
drug prices
exome
fda
generic drugs
life science
medicare
What
long
10
×
drug
awaited
house
medicine
medicines
plan
ago
data
details
drugs
lasting
lower
prices
rna
trump
unveiled
white
abandoning
adapt
administration
afternoon
alike
alnylam
anathema
anticipated
antonio
badylak
baggage
based
biotech
biotechs
blueprint
canada
canadian
cells
cellular
changes
cheaper
cholesterol
Language
unset
unknown
Current search:
long
×
photo
×
" boston blog main "
×
biotech
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
@xconomy.com
4 years ago
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details